Hong Kong has the highest life expectancy in the world thanks to its advanced healthcare services, and the city expects a more ageing population similar to many developed economies in the coming years. The number of elderly people aged 65 or above is projected to increase from 20% of the total population in 2021 to 32% in 2041.
CBP determined on 28 March that certain Norwegian-origin omega-3-acid ethyl esters do not undergo a substantial transformation in mainland China when combined with certain inactive ingredients and encapsulated into dosage form and are therefore a product of Norway and are not subject to any Section 301 tariffs.
The two lawmakers at the helm of the influential House Select Committee on the Strategic Competition Between the U.S. and the Chinese Communist Party are calling for enhanced scrutiny of mainland Chinese biotech companies.
In a recent hearing before the House Subcommittee on Oversight and Investigations, a Government Accountability Office official reiterated the challenges faced by the Food and Drug Administration in overseeing foreign drug manufacturing facilities.
In order to explore the potential opportunities for collaboration between Hong Kong and South Korean start-ups, HKTDC Research went to the South Korean capital Seoul to conduct a field study. We talked to a number of South Korean start-ups in the fintech and wellness sector, as well as other industry stakeholders, in order to get a better understanding of the country’s start-up landscape and the evolving opportunities there. Hong Kong is not only an international financial centre and a fintech hub, it also boasts a vibrant start-up scene which appeals to South Korean start-ups in many different sectors, including those in the health and wellness field.